Scott-Levin Announces Disease Management Policy Alerts: How and When States Look to Control Drug Costs for Chronic Conditions Business Wire
click here to return to Business Wire main menu
DonateNow





Scott-Levin Announces Disease Management Policy Alerts: How and When States Look to Control Drug Costs for Chronic Conditions

Business Wire - November 14, 2001


NEWTOWN, Pa.-- State government officials see pharmaceutical spending for chronic diseases as an opportunity to control health care costs.

Disease Management Policy Alerts, designed to provide a detailed look at state programs, legislation and regulations affecting chronic diseases, has been launched by Scott-Levin, a Quintiles Transnational company (Nasdaq: QTRN). The first report addresses asthma and includes:

-- An overview of the disease's demographic, economic and social impact;

-- A comprehensive look at recent state legislative and regulatory disease-specific initiatives;

-- Private-sector patient advocacy and assistance programs;

-- Key federal disease initiatives;

-- Market statistics on medication uses, prescribing and promotion;

-- Managed care disease-management issues and aggregate statistics on drug coverage;

-- A recap of current and future drug treatments for the disease.

The second report in the series, which targets HIV/AIDS services and treatments, will be available in late November 2001. Reports now being developed cover diabetes, cancer, depression and psychosis, hepatitis, stroke, obesity, and influenza.

For more information, clients can contact Theresa Regan at theresa.regan@scottlevin.com. Media representatives should contact Kevin Monaghan at kevin.monaghan@scottlevin.com. Phone: 215/860-0440; Fax: 215/860-5477.

Scott-Levin, a part of Quintiles Informatics, provides consulting services to more than 100 U.S. and international pharmaceutical clients. These services monitor key areas such as product promotion, industry trends, retail pharmacy activity, market performance, managed care and government affairs.

Scott-Levin's market research audits and strategic studies cover detailing, meetings and events, direct-to-consumer advertising, journal advertising, and other media. Taken together, Scott-Levin products can give clients the most accurate possible picture of total pharmaceutical promotion.

Quintiles Transnational Corp. is the world's leading provider of information, technology and services to bring new medicines to patients faster and improve health care. Headquartered near Research Triangle Park, N.C., Quintiles is a member of the S&P 500 and Fortune 1000. For more information, visit the company's Web site at www.quintiles.com.

--30--clf/ix*

CONTACT: Scott-Levin Clients Theresa Regan theresa.regan@scottlevin.com Media Kevin Monaghan kevin.monaghan@scottlevin.com 800/982-5613 215/860-0440 Fax: 215/860-5477 www.scottlevin.com
011114
BW011112


Copyright © 2001 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .